sorafenib has been researched along with Polycystic Ovary Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Gao, ZH; Guo, XC; Ji, M; Li, L; Wang, QQ | 1 |
1 other study(ies) available for sorafenib and Polycystic Ovary Syndrome
Article | Year |
---|---|
Treatment with metformin and sorafenib alleviates endometrial hyperplasia in polycystic ovary syndrome by promoting apoptosis via synergically regulating autophagy.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Drug Synergism; Endometrial Hyperplasia; Female; Metformin; Polycystic Ovary Syndrome; Rats; Rats, Sprague-Dawley; Sorafenib | 2020 |